✦ LIBER ✦

14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers

✍ Scribed by Yukiko Nakamura, Kazuteru Oshima, Yasuto Naoi, Takahiro Nakayama, Seung Jin Kim, Kenzo Shimazu, Atsushi Shimomura, Naomi Maruyama, Yasuhiro Tamaki, Shinzaburo Noguchi

Book ID: 113062427
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 338 KB
Volume: 134
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-1976-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GSTP1 expression predicts poor pathologi

GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer

✍ Tomohiro Miyake; Takahiro Nakayama; Yasuto Naoi; Noriaki Yamamoto; Yoko Otani; S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

Neoadjuvant Chemotherapy Is Associated w

Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

✍ Carla S. Fisher; Cynthia X. Ma; William E. Gillanders; Rebecca L. Aft; Timothy J 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Common and discriminative clinicopatholo

Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy

✍ Tomo Osako; Rie Horii; Masaaki Matsuura; Akiko Ogiya; Kaoru Domoto; Yumi Miyagi; 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 365 KB

Syndecan-1 (CD138) expression in human b

Syndecan-1 (CD138) expression in human breast carcinoma is associated with an aggressive phenotype and appears related to a poor prognosis and low response to adjuvant chemotherapy

✍ E. Galligioni; M. Barbareschi; D. Aldovini; P. Maisonneuuve; M.G. Cangi; L. Pecc 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 175 KB